Project Details
Description
The hypothalamus, consisting of multiple nuclei, regulates homeostasis crucial for survival and reproduction. In
particular, the hypothalamic arcuate nucleus (ARC) has various neurons that control energy balance,
reproduction, and growth and play key roles in sensing and processing peripheral cues due to its permeability
and proximity to the peripheral bloodstream. Despite the vital roles of ARC neurons in the growth and energy
homeostasis, the transcription factors (TFs) and epigenetic regulatory programs that orchestrate their
development remain poorly understood. In this proposal, we wish to fill this gap by studying MLL4-complex
(MLL4-C) and its partner TFs in ARC development. MLL4-C acts as an epigenetic coactivator of its partner TFs
by utilizing its two histone H3-modifying enzyme subunits; the H3-lysine 4-methyltransferase (H3K4MT) MLL4
and the H3K27-demethylase (H3K27DM) UTX. In humans, mutations in MLL4 or UTX cause a developmental
disorder Kabuki syndrome (KS) characterized by a unique facial feature, microcephaly, heart defects,
intellectual disability, dwarfism and obesity. Our strong preliminary results suggest that the attenuated activity
of MLL4-C in the ARC results in deficits in ARC neuronal development and contributes to the short stature and
obesity observed in human KS, leading to the major hypothesis of this proposal: By interacting with partner
TFs, MLL4-C is recruited to the genes critical for ARC neuronal fate determination and neurite/axonal
growth and upregulates their expression using the chromatin-opening activities of MLL4/UTX. Using an
ensemble of cell and molecular, biochemical, mouse genetics, and genome-wide approaches, we will test this
hypothesis in three specific aims. This study will reveal fundamental principles of genetic and epigenetic
regulatory programs that direct ARC neuronal development, establishing the concept that MLL4-C is a
therapeutic target to treat various pathologies of KS.
| Status | Finished |
|---|---|
| Effective start/end date | 06/1/20 → 05/31/21 |
Funding
- National Inst of Diabetes Digestive Kidney Disease: $81,002.27
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.